Covid-19

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 37

Coronavirus Update 69.

Quick Hits and other musings –
1) In the interview with Dr. Offit there were a few big take aways:
  • Boosters for non risk based teen and young adults are unlikely to provide benefit while offering a small but real level of risk from myocarditis
  • Boosters are offering minimal benefit to the nation from a transmission perspective. At best 8-12 weeks of protection against symptomatic disease
  • Dr. Offit voted against adding omicron antigens to this fall’s booster as there was limited data that it would any benefit. He was in the minority at the FDA advisory meeting, thus this fall’s booster will have new strain genetics in it
  • The boosters could, not shown yet in humans, block future variant immunity to newer strains through viral immune imprinting

A lot more this week to digest.

Dr. M

Dr. M’s SPA Newsletter Volume 11 Issue 27 Covid Update #38

Just when you think that the information on SARS2 Covid19 is slowing to a crawl with new discovery, a favorite researcher publishes a truly remarkable bit of scientific discovery. Dr. Alessio Fasano is featured below in Number 6 and his work is really important. A little science heavy but critical for children. There is a take home summary as well. Don’t miss this information.
Quick hits
1) CDC data on adolescent hospitalizations: COVID-19 adolescent hospitalization rates from COVID-NET peaked at 2.1 per 100,000 in early January 2021, declined to 0.6 in mid-March, and rose to 1.3 in April. Among hospitalized adolescents, nearly one third required intensive care unit admission, and 5% required invasive mechanical ventilation; no associated deaths occurred….. Read more at this link: https://www.salisburypediatrics.com/patient-education/dr-magryta-s-newsletter/964-volume-11-letter-27-coronavirus-update-38

Dr. Magryta’s Newsletter Coronavirus Update #36

We must have discourse regarding experimental vaccinations to be a moral society. For this reason, I will take on this controversial topic.
Are we all ok with an emergency use authorization for the COVID19 vaccine for children under age 16 years old? That is a loaded question. In the British Medical Journal we see a piece written by Drs. Pegden, Prasad and Baral this week. They state: “For adults, the benefits of covid-19 vaccination are enormous, while for children they are relatively minor. Rare side effects from adult covid-19 vaccination are unlikely to lead to future vaccine hesitancy whose public health impact could be comparable to the benefits of the adult covid-19 vaccination program itself. But accelerated mass child vaccination under emergency use authorization—perhaps even spurred by school mandates and “vaccine passports”—presents a different balance of risks and benefits. The possibility that rare adverse events could emerge as the more durable public health legacy of an emergency use authorization for child covid-19 vaccines is much greater.” (Pegden et. al. 2021)…….
If you prefer to read the newsletter or see the references, go to https://www.salisburypediatrics.com/patient-education/dr-magryta-s-newsletter/954-volume-11-letter-23-coronavirus-update-36

Protected: 6 Ways Covid Vaccine Hesitancy is Harming Children (Pedcast by Doc Smo and Sonya Corina Williams)

This content is password protected. To view it please enter your password below:

Protected: Covid-19 Preventable in Kids-Magryta M.D. Says Yes (Pedcast)

This content is password protected. To view it please enter your password below:

Protected: Covid-19 in Children: What Have We Learned So Far? (Pedcast by Doc Smo and Sonya Corina Williams)

This content is password protected. To view it please enter your password below: